Convidado
CAMILA MARTINS FONSECA GALIZZI
Atividades
09/04/2022
10:50 às 12:20 - Módulo 3
11:20 às 11:30 - CTIM-25 - A randomized phase 3 study of nivolumab or placebo combined with radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma with methylated MGMT promoter: CheckMate 548
Palestrante
09/04/2022
10:50 às 12:20 - Módulo 3
11:20 às 11:30 - CTIM-13 - Phase 1 Clinical Trial of Oncolytic Viral Immunotherapy with CAN-2409 + Valacyclovir in Combination with Nivolumab and Standard of Care (SOC) in Newly Diagnosed High-Grade Glioma (HGG)
Palestrante
09/04/2022
10:50 às 12:20 - Módulo 3
12:05 às 12:20 - Discussão ao vivo
Palestrante
